Search Results
May 08, 2026, 07:00 ET Calumet Reports First Quarter 2026 Results
regarding our business outlook and cash flows, including with respect to the Montana Renewables business and our plans to de-leverage our balance sheet, (iii) our ability to monetize federal clean fuel production tax credits ("CFPCs") under Section 45Z of the Internal Revenue Code and the price we expect to
More news about: Calumet, Inc.
May 08, 2026, 06:50 ET RE/MAX HOLDINGS, INC. REPORTS FIRST QUARTER 2026 RESULTS
organic revenue growth as revenue growth from continuing operations excluding (i) revenue from Marketing Funds, (ii) revenue from acquisitions, and (iii) the impact of foreign currency movements. The Company defines revenue from acquisitions as the revenue generated from the date of an acquisition to
More news about: RE/MAX Holdings, Inc.
May 08, 2026, 06:45 ET TELUS reports operational and financial results for first quarter 2026
acquisitions and growth in payor and provider solutions; (ii) subscriber base growth across mobile, residential internet, security and automation and TV; and (iii) higher residential internet revenue per customer. These factors were partially offset by: (i) mobile phone ARPU declining at a decelerating rate; (ii)
More news about: TELUS Corporation
May 08, 2026, 06:45 ET TELUS reports operational and financial results for first quarter 2026
acquisitions and growth in payor and provider solutions; (ii) subscriber base growth across mobile, residential internet, security and automation and TV; and (iii) higher residential internet revenue per customer. These factors were partially offset by: (i) mobile phone ARPU declining at a decelerating rate; (ii)
More news about: TELUS Corporation
May 08, 2026, 06:40 ET The sNDA for Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First‑Line Treatment for PD-L1-positive NSCLC Accepted for Review by NMPA
(TPS) ≥1% and are EGFR-negative and ALK-negative. This acceptance is based on the positive results from the OptiTROP-Lung05 registrational Phase III study, and the application is the fifth indication application for sac-TMT that has been accepted by the NMPA.
More news about: Kelun-Biotech
May 08, 2026, 06:15 ET Guangdong province: 139th Canton Fair sets new record with overseas buyer attendance
Phase II debuted zones for bamboo and wood household products and tableware, integrated housing and outdoor facilities, and trendy accessories. Phase III added a zone for functional and technical fabrics. Nearly 670 enterprises took part in these specialized zones, erecting more than 1,300 booths and highlighting
More news about: Guangdong Province
May 08, 2026, 06:05 ET Guangdong province: 139th Canton Fair sets new record with overseas buyer attendance
Phase II debuted zones for bamboo and wood household products and tableware, integrated housing and outdoor facilities, and trendy accessories. Phase III added a zone for functional and technical fabrics. Nearly 670 enterprises took part in these specialized zones, erecting more than 1,300 booths and highlighting
More news about: Guangdong Province
May 08, 2026, 06:05 ET Pameran Kanton ke-139 mencetak rekor baru dalam jumlah kehadiran pembeli luar negeri
memperkenalkan zona untuk produk rumah tangga berbahan bambu dan kayu serta peralatan makan, hunian terpadu dan fasilitas luar ruang, serta aksesori tren. Tahap III menambahkan zona untuk kain fungsional dan teknis. Hampir 670 perusahaan berpartisipasi dalam zona-zona khusus ini dengan mendirikan lebih dari 1.300
More news about: Guangdong Province
May 08, 2026, 06:05 ET Guangdong province: La 139.ª Feria de Cantón establece un nuevo récord de asistencia de compradores internacionales
zonas para productos domésticos de bambú y madera y vajillas, viviendas integradas e instalaciones al aire libre, así como accesorios de moda. La Fase III añadió una zona para tejidos funcionales y técnicos. Cerca de 670 empresas participaron en estas zonas especializadas, instalando más de 1.300 stands
More news about: Guangdong Province
May 08, 2026, 06:00 ET Century Casinos, Inc. Announces First Quarter 2026 Results
Midwest includes the Century Casinos & Hotels in Cape Girardeau and Caruthersville, Missouri, and in Cripple Creek and Central City, Colorado; (iii) US West includes the Nugget Casino Resort in Reno-Sparks, Nevada; (iv) Canada includes Century Casino & Hotel in Edmonton, the Century Casino in
More news about: Century Casinos, Inc.
May 07, 2026, 20:30 ET Chance Pharma Announces NMPA Acceptance of New Drug Application for Investigational Respiratory Drug CXG87
positive top-line results from the Phase III clinical trial of CXG87. CXG87 demonstrated advantages across multiple clinically meaningful endpoints, including lung function, overall asthma control, quality of life, and treatment satisfaction. The findings from the Phase III study are consistent with data from
More news about: Chance Pharmaceuticals
May 07, 2026, 19:01 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Graphic Packaging Holding Company and Certain Former Officers - GPK
and severity of the foregoing issues, which were likely to, and did, have a material negative impact on the Company's business and financial results; (iii) Defendants likewise overstated the strength and sustainability of the Company's business model and operations, as well as its ability to weather ongoing
More news about: Pomerantz LLP
May 07, 2026, 18:44 ET Hexagon Composites ASA: Key information relating to potential subsequent offering
thereafter) who (i) were not included in the pre-sounding phase of the Private Placement, (ii) were not allocated shares in the Private Placement and (iii) are not resident in a jurisdiction where such offering would be unlawful, or would (in jurisdictions other than Norway) require any prospectus filing,
More news about: Hexagon Composites ASA
May 07, 2026, 17:38 ET INVESTOR DEADLINE: Medpace Holdings Inc. (MEDP) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
book-to-bill ratio for fourth quarter 2025; (ii) Medpace knew or recklessly disregarded the impact that cancellations have on Medpace's book-to-bill ratio; (iii) Medpace frequently claimed that the projection of a 1.15 book-to-bill ratio for fourth quarter 2025 was reasonable and achievable and that cancellations
More news about: Robbins Geller Rudman & Dowd LLP
May 07, 2026, 17:36 ET Robbins LLP Reminds UPST Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About Leading the Class Action Against Upstart Holdings, Inc.
performing its risk-separation processes; (ii) accordingly, Model 22's overall accuracy and propensity to increase loan approval rates were overstated; and (iii) Model 22's overly conservative assessment of credit and macroeconomic conditions was having a significant negative impact on Upstart's revenue results,
More news about: Robbins LLP
May 07, 2026, 17:17 ET FSK INVESTOR ALERT: FS KKR Capital Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
(ii) FS KKR overstated the valuation of its portfolio investments and/or overstated the effectiveness of FS KKR's portfolio valuation process; and (iii) FS KKR overstated the durability of its quarterly distribution strategy.The FS KKR class action lawsuit further alleges that
More news about: Robbins Geller Rudman & Dowd LLP
May 07, 2026, 17:00 ET Wheaton Precious Metals Announces Record Revenue, Earnings and Cash Flow for the First Quarter of 2026
3)Refer to discussion on non-GAAP measure (iii) at the end of this press release.4)
More news about: Wheaton Precious Metals Corp.
May 07, 2026, 16:30 ET Hyperscale Data Evaluating Strategic Alternatives as Balance Sheet Strength Continues to Exceed Public Market Valuation
valuation and what we believe are the underlying values of our balance sheet, infrastructure assets and operating businesses," said Milton "Todd" Ault III, Executive Chairman of Hyperscale Data. "With nearly $100 million in combined cash and Bitcoin holdings, a substantial AI-focused data center
More news about: Hyperscale Data Inc.
May 07, 2026, 16:20 ET MAIN STREET ANNOUNCES FIRST QUARTER 2026 RESULTS
beginning of the comparable period of the prior year through our (i) at-the-market ("ATM") equity issuance program, (ii) dividend reinvestment plan and (iii) equity incentive compensation plans. The decrease in NII on a per share basis in the first quarter of 2026 is after a net increase of $0.01 per share
More news about: Main Street Capital Corporation
May 07, 2026, 16:15 ET FS Credit Opportunities Corp. (FSCO) Declares Distribution for May 2026
these funds, including uncalled investor capital commitments from which Future Standard is currently not earning management fees or carried interest; (iii) the value of outstanding CLOs (excluding CLOs wholly-owned by Future Standard); (iv) the fair value of FS KKR Capital Corp. joint venture (JV) assets
More news about: Future Standard
May 07, 2026, 16:15 ET FS Specialty Lending Fund (FSSL) Declares Distribution for May 2026
these funds, including uncalled investor capital commitments from which Future Standard is currently not earning management fees or carried interest; (iii) the value of outstanding CLOs (excluding CLOs wholly-owned by Future Standard); (iv) the fair value of FS KKR Capital Corp. joint venture (JV) assets
More news about: Future Standard
May 07, 2026, 16:15 ET Drilling Tools International Corp. Reports 2026 First Quarter Results
depreciation and amortization, further adjusted for (i) goodwill and/or long-lived asset impairment charges, (ii) stock-based compensation expense, (iii) restructuring charges, (iv) transaction and integration costs related to acquisitions and (v) other expenses or charges to exclude certain items that
More news about: Drilling Tools International Corp.
May 07, 2026, 16:15 ET Nektar Therapeutics Reports First Quarter 2026 Financial Results
including negative safety and efficacy findings in future clinical studies (notwithstanding positive findings in earlier preclinical and clinical studies); (iii) rezpegaldesleukin, NKTR-0165, NKTR-0166 and NKTR-422 are in clinical development and the risk of failure is high and can unexpectedly occur at any stage
More news about: Nektar Therapeutics
May 07, 2026, 16:15 ET MSC INCOME FUND ANNOUNCES FIRST QUARTER 2026 RESULTS
increase was principally attributable to (i) a $0.7 million increase in interest expense, (ii) a $0.3 million increase in base management fees and (iii) a $0.1 million increase in incentive fee on income, net of waivers, partially offset by a $0.6 million decrease in the ending accrual for the accrued
More news about: MSC Income Fund, Inc.
May 07, 2026, 16:15 ET American Healthcare REIT Announces First Quarter 2026 Results; Increases Full Year 2026 Guidance
an indicator of our operating performance, (ii) more relevant or accurate than GAAP cash flows from operations as an indicator of our liquidity or (iii) indicative of funds available to fund our cash needs, including our ability to make distributions to our stockholders. The method utilized to evaluate
More news about: American Healthcare REIT, Inc.